<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 03 Jun 2026 05:12:04 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Danaher (DHR) PT Lowered to $230 at HSBC</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/Danaher+%28DHR%29+PT+Lowered+to+%24230+at+HSBC/26594511.html</link>
   <description>HSBC analyst Rajesh Kumar lowered the price target on Danaher (NYSE: DHR) to $230.00  (from $270.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/Danaher+%28DHR%29+PT+Lowered+to+%24230+at+HSBC/26594511.html</guid>
   <pubDate>Wed, 03 Jun 2026 05:12:04 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	  </item>
  <item>
   <title>DZ Bank Starts Danaher (DHR) at Buy</title>
   <link>http://www.streetinsider.com/New+Coverage/DZ+Bank+Starts+Danaher+%28DHR%29+at+Buy/26594435.html</link>
   <description>&lt;p&gt;DZ Bank initiates coverage on Danaher (NYSE: DHR) with a Buy rating and a price target of $210.00.&lt;/p&gt;&lt;p&gt;For an analyst ratings summary and ratings history on Danaher &lt;a href=&quot;http://www.streetinsider.com/rating_history.php?q=DHR&quot;&gt;click here&lt;/a&gt;. For more ratings news on Danaher &lt;a href=&quot;http://www.streetinsider.com/stock_lookup_news.php?q=DHR&amp;amp;type=analyst&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Shares of Danaher closed at $176.11 yesterday.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/DZ+Bank+Starts+Danaher+%28DHR%29+at+Buy/26594435.html</guid>
   <pubDate>Wed, 03 Jun 2026 04:51:57 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	  </item>
  <item>
   <title>Wolfe Research Assumes Danaher (DHR) at Peerperform</title>
   <link>http://www.streetinsider.com/New+Coverage/Wolfe+Research+Assumes+Danaher+%28DHR%29+at+Peerperform/26583325.html</link>
   <description>(Updated - June 1, 2026 4:29 PM EDT)

&lt;p&gt;Wolfe Research analyst Mike Polark assumes coverage on Danaher (NYSE: DHR) with a Peerperform rating.&lt;/p&gt;&lt;p&gt;The analyst comments &quot;We rate DHR shares Peer Perform and frame fair value of $165-$185 per share which represents 18-20 times on our 2027 EPS estimate. Our model includes the ~$10B MASI acquisition accretion – we have the deal closing July 1 thus is a stub impact in 2026 and shows the full 15c-20c of guided Year 1 accretion in 2027. This applied P/E range approximates the sector multiple. Like TMO, given its scale, DHR in many ways approximates</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/Wolfe+Research+Assumes+Danaher+%28DHR%29+at+Peerperform/26583325.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:29:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	  </item>
  <item>
   <title>Wolfe Research Assumes Danaher (DHR) at Peerperform</title>
   <link>http://www.streetinsider.com/Analyst+Comments/Wolfe+Research+Assumes+Danaher+%28DHR%29+at+Peerperform/26583325.html</link>
   <description>(Updated - June 1, 2026 4:29 PM EDT)

&lt;p&gt;Wolfe Research analyst Mike Polark assumes coverage on Danaher (NYSE: DHR) with a Peerperform rating.&lt;/p&gt;&lt;p&gt;The analyst comments &quot;We rate DHR shares Peer Perform and frame fair value of $165-$185 per share which represents 18-20 times on our 2027 EPS estimate. Our model includes the ~$10B MASI acquisition accretion – we have the deal closing July 1 thus is a stub impact in 2026 and shows the full 15c-20c of guided Year 1 accretion in 2027. This applied P/E range approximates the sector multiple. Like TMO, given its scale, DHR in many ways approximates</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+Comments/Wolfe+Research+Assumes+Danaher+%28DHR%29+at+Peerperform/26583325.html</guid>
   <pubDate>Mon, 01 Jun 2026 16:29:06 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	  </item>
  <item>
   <title>SCIEX expands ZenoTOF platform with new software and partnerships</title>
   <link>http://www.streetinsider.com/Corporate+News/SCIEX+expands+ZenoTOF+platform+with+new+software+and+partnerships/26582540.html</link>
   <description>&lt;p&gt;SCIEX, a Danaher company, announced platform-wide enhancements to its ZenoTOF mass spectrometry line at the ASMS conference. The updates include new software features, expanded hardware compatibility, and software collaborations for life science research applications.&lt;/p&gt;&lt;p&gt;The company released SCIEX OS 5.0 software with new features including Central Metrics Tracker, Central Monitoring, Reporter Template Creator, and AI-enabled functions. The software introduces ZT Scan DIA 3.0, which combines data-independent acquisition with narrower isolation windows. SCIEX reported that the enhanced sensitivity mode on the ZenoTOF 8600 system showed 10% to 40% improvements in identification and quantitation for low-input proteomics workflows.&lt;/p&gt;&lt;p&gt;New hardware integrations include compatibility with</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/SCIEX+expands+ZenoTOF+platform+with+new+software+and+partnerships/26582540.html</guid>
   <pubDate>Mon, 01 Jun 2026 14:00:48 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	  </item>
  <item>
   <title>SCIEX launches novus V55 mass spectrometer with AI-enabled software</title>
   <link>http://www.streetinsider.com/Corporate+News/SCIEX+launches+novus+V55+mass+spectrometer+with+AI-enabled+software/26582534.html</link>
   <description>&lt;p&gt;SCIEX, a Danaher company, announced the launch of its novus V55 system, a triple quadrupole mass spectrometer designed for laboratory analytical testing. The company unveiled the product at the ASMS conference.&lt;/p&gt;&lt;p&gt;The novus V55 system features accelerated MRM technology that can acquire up to 1,000 MRMs per second. The system has a 35% smaller footprint compared to the SCIEX 5500+ system and uses 40% less energy while reducing laboratory cooling requirements by the same percentage.&lt;/p&gt;&lt;p&gt;The system includes SCIEX OS 5.0 software with several new features. The Central Metrics Tracker monitors performance and assay level metrics, while Central Monitoring displays instrument status</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/SCIEX+launches+novus+V55+mass+spectrometer+with+AI-enabled+software/26582534.html</guid>
   <pubDate>Mon, 01 Jun 2026 14:00:43 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	  </item>
  <item>
   <title>SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations</title>
   <link>http://www.streetinsider.com/Press+Releases/SCIEX+Advances+the+ZenoTOF+Line+With+Platform-Wide+Expansions+in+Software%2C+Integrations%2C+and+Key+Collaborations/26582511.html</link>
   <description>
&lt;p&gt;    MARLBOROUGH, Mass.--(BUSINESS WIRE)--
At ASMS, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sciex.com&amp;amp;esheet=54545423&amp;amp;newsitemid=20260601890868&amp;amp;lan=en-US&amp;amp;anchor=SCIEX&amp;amp;index=1&amp;amp;md5=c0cfe5b6579608a0a73a7acb23890ef4&quot; shape=&quot;rect&quot;&gt;SCIEX&lt;/a&gt;, a Danaher company and leader in life science analytical technologies, introduced platform-wide advancements across its accurate mass ZenoTOF line. The updates include new SCIEX OS 5.0 software features, broader front-end compatibility, and forward-looking software collaborations designed to help omics researchers solve complex biological questions. This connected environment reduces workflow complexity, while enabling deeper, more actionable insights from a single, dynamic platform.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;SCIEX OS 5.0 software&lt;/b&gt; introduces new features including Central Metrics Tracker, Central Monitoring, Reporter Template Creator, an AI enabled “helpme” function, and AI enabled Calculated Columns. Additional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SCIEX+Advances+the+ZenoTOF+Line+With+Platform-Wide+Expansions+in+Software%2C+Integrations%2C+and+Key+Collaborations/26582511.html</guid>
   <pubDate>Mon, 01 Jun 2026 14:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	  </item>
  <item>
   <title>SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations</title>
   <link>http://www.streetinsider.com/Press+Releases/SCIEX+Advances+the+ZenoTOF+Line+With+Platform-Wide+Expansions+in+Software%2C+Integrations%2C+and+Key+Collaborations/26582511.html</link>
   <description>
&lt;p&gt;    MARLBOROUGH, Mass.--(BUSINESS WIRE)--
At ASMS, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sciex.com&amp;amp;esheet=54545423&amp;amp;newsitemid=20260601890868&amp;amp;lan=en-US&amp;amp;anchor=SCIEX&amp;amp;index=1&amp;amp;md5=c0cfe5b6579608a0a73a7acb23890ef4&quot; shape=&quot;rect&quot;&gt;SCIEX&lt;/a&gt;, a Danaher company and leader in life science analytical technologies, introduced platform-wide advancements across its accurate mass ZenoTOF line. The updates include new SCIEX OS 5.0 software features, broader front-end compatibility, and forward-looking software collaborations designed to help omics researchers solve complex biological questions. This connected environment reduces workflow complexity, while enabling deeper, more actionable insights from a single, dynamic platform.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;SCIEX OS 5.0 software&lt;/b&gt; introduces new features including Central Metrics Tracker, Central Monitoring, Reporter Template Creator, an AI enabled “helpme” function, and AI enabled Calculated Columns. Additional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SCIEX+Advances+the+ZenoTOF+Line+With+Platform-Wide+Expansions+in+Software%2C+Integrations%2C+and+Key+Collaborations/26582511.html</guid>
   <pubDate>Mon, 01 Jun 2026 14:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	  </item>
  <item>
   <title>SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations</title>
   <link>http://www.streetinsider.com/Business+Wire/SCIEX+Advances+the+ZenoTOF+Line+With+Platform-Wide+Expansions+in+Software%2C+Integrations%2C+and+Key+Collaborations/26582511.html</link>
   <description>
&lt;p&gt;    MARLBOROUGH, Mass.--(BUSINESS WIRE)--
At ASMS, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sciex.com&amp;amp;esheet=54545423&amp;amp;newsitemid=20260601890868&amp;amp;lan=en-US&amp;amp;anchor=SCIEX&amp;amp;index=1&amp;amp;md5=c0cfe5b6579608a0a73a7acb23890ef4&quot; shape=&quot;rect&quot;&gt;SCIEX&lt;/a&gt;, a Danaher company and leader in life science analytical technologies, introduced platform-wide advancements across its accurate mass ZenoTOF line. The updates include new SCIEX OS 5.0 software features, broader front-end compatibility, and forward-looking software collaborations designed to help omics researchers solve complex biological questions. This connected environment reduces workflow complexity, while enabling deeper, more actionable insights from a single, dynamic platform.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;SCIEX OS 5.0 software&lt;/b&gt; introduces new features including Central Metrics Tracker, Central Monitoring, Reporter Template Creator, an AI enabled “helpme” function, and AI enabled Calculated Columns. Additional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/SCIEX+Advances+the+ZenoTOF+Line+With+Platform-Wide+Expansions+in+Software%2C+Integrations%2C+and+Key+Collaborations/26582511.html</guid>
   <pubDate>Mon, 01 Jun 2026 14:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	  </item>
  <item>
   <title>SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations</title>
   <link>http://www.streetinsider.com/Business+Wire/SCIEX+Advances+the+ZenoTOF+Line+With+Platform-Wide+Expansions+in+Software%2C+Integrations%2C+and+Key+Collaborations/26582511.html</link>
   <description>
&lt;p&gt;    MARLBOROUGH, Mass.--(BUSINESS WIRE)--
At ASMS, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sciex.com&amp;amp;esheet=54545423&amp;amp;newsitemid=20260601890868&amp;amp;lan=en-US&amp;amp;anchor=SCIEX&amp;amp;index=1&amp;amp;md5=c0cfe5b6579608a0a73a7acb23890ef4&quot; shape=&quot;rect&quot;&gt;SCIEX&lt;/a&gt;, a Danaher company and leader in life science analytical technologies, introduced platform-wide advancements across its accurate mass ZenoTOF line. The updates include new SCIEX OS 5.0 software features, broader front-end compatibility, and forward-looking software collaborations designed to help omics researchers solve complex biological questions. This connected environment reduces workflow complexity, while enabling deeper, more actionable insights from a single, dynamic platform.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;SCIEX OS 5.0 software&lt;/b&gt; introduces new features including Central Metrics Tracker, Central Monitoring, Reporter Template Creator, an AI enabled “helpme” function, and AI enabled Calculated Columns. Additional</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/SCIEX+Advances+the+ZenoTOF+Line+With+Platform-Wide+Expansions+in+Software%2C+Integrations%2C+and+Key+Collaborations/26582511.html</guid>
   <pubDate>Mon, 01 Jun 2026 14:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	  </item>
  <item>
   <title>SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools</title>
   <link>http://www.streetinsider.com/Press+Releases/SCIEX+Launches+the+novus+V55+System+With+SCIEX+OS+5.0+Software+and+AI+Enablement+Tools/26582514.html</link>
   <description>
&lt;p&gt;    MARLBOROUGH, Mass.--(BUSINESS WIRE)--
At ASMS, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sciex.com&amp;amp;esheet=54545425&amp;amp;newsitemid=20260601916060&amp;amp;lan=en-US&amp;amp;anchor=SCIEX&amp;amp;index=1&amp;amp;md5=1a1a904d9ab3735f1cc2e39abab752ea&quot; shape=&quot;rect&quot;&gt;SCIEX&lt;/a&gt;, a Danaher company and leader in life science analytical technologies, launched the novus V55 system - a next-generation triple quadrupole mass spectrometer designed for the realities of high-pressure, results-driven labs. The system provides exceptional sensitivity and accelerated output, in a smaller footprint and with improved energy efficiency when compared to the SCIEX 5500+ system. This quantitative solution expands testing capabilities across pesticide and food analysis, pharmaceutical impurities, bioanalysis, PFAS testing and additional applications.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features multimedia. View the full release here: &lt;a target=&quot;_blank&quot; href=&quot;https://www.businesswire.com/news/home/20260601916060/en/&quot; rel=&quot;nofollow&quot;&gt;https://www.businesswire.com/news/home/20260601916060/en/&lt;/a&gt;&lt;/p&gt;&lt;div</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SCIEX+Launches+the+novus+V55+System+With+SCIEX+OS+5.0+Software+and+AI+Enablement+Tools/26582514.html</guid>
   <pubDate>Mon, 01 Jun 2026 14:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	  </item>
  <item>
   <title>SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools</title>
   <link>http://www.streetinsider.com/Press+Releases/SCIEX+Launches+the+novus+V55+System+With+SCIEX+OS+5.0+Software+and+AI+Enablement+Tools/26582514.html</link>
   <description>
&lt;p&gt;    MARLBOROUGH, Mass.--(BUSINESS WIRE)--
At ASMS, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sciex.com&amp;amp;esheet=54545425&amp;amp;newsitemid=20260601916060&amp;amp;lan=en-US&amp;amp;anchor=SCIEX&amp;amp;index=1&amp;amp;md5=1a1a904d9ab3735f1cc2e39abab752ea&quot; shape=&quot;rect&quot;&gt;SCIEX&lt;/a&gt;, a Danaher company and leader in life science analytical technologies, launched the novus V55 system - a next-generation triple quadrupole mass spectrometer designed for the realities of high-pressure, results-driven labs. The system provides exceptional sensitivity and accelerated output, in a smaller footprint and with improved energy efficiency when compared to the SCIEX 5500+ system. This quantitative solution expands testing capabilities across pesticide and food analysis, pharmaceutical impurities, bioanalysis, PFAS testing and additional applications.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features multimedia. View the full release here: &lt;a target=&quot;_blank&quot; href=&quot;https://www.businesswire.com/news/home/20260601916060/en/&quot; rel=&quot;nofollow&quot;&gt;https://www.businesswire.com/news/home/20260601916060/en/&lt;/a&gt;&lt;/p&gt;&lt;div</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/SCIEX+Launches+the+novus+V55+System+With+SCIEX+OS+5.0+Software+and+AI+Enablement+Tools/26582514.html</guid>
   <pubDate>Mon, 01 Jun 2026 14:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	  </item>
  <item>
   <title>SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools</title>
   <link>http://www.streetinsider.com/Business+Wire/SCIEX+Launches+the+novus+V55+System+With+SCIEX+OS+5.0+Software+and+AI+Enablement+Tools/26582514.html</link>
   <description>
&lt;p&gt;    MARLBOROUGH, Mass.--(BUSINESS WIRE)--
At ASMS, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sciex.com&amp;amp;esheet=54545425&amp;amp;newsitemid=20260601916060&amp;amp;lan=en-US&amp;amp;anchor=SCIEX&amp;amp;index=1&amp;amp;md5=1a1a904d9ab3735f1cc2e39abab752ea&quot; shape=&quot;rect&quot;&gt;SCIEX&lt;/a&gt;, a Danaher company and leader in life science analytical technologies, launched the novus V55 system - a next-generation triple quadrupole mass spectrometer designed for the realities of high-pressure, results-driven labs. The system provides exceptional sensitivity and accelerated output, in a smaller footprint and with improved energy efficiency when compared to the SCIEX 5500+ system. This quantitative solution expands testing capabilities across pesticide and food analysis, pharmaceutical impurities, bioanalysis, PFAS testing and additional applications.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features multimedia. View the full release here: &lt;a target=&quot;_blank&quot; href=&quot;https://www.businesswire.com/news/home/20260601916060/en/&quot; rel=&quot;nofollow&quot;&gt;https://www.businesswire.com/news/home/20260601916060/en/&lt;/a&gt;&lt;/p&gt;&lt;div</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/SCIEX+Launches+the+novus+V55+System+With+SCIEX+OS+5.0+Software+and+AI+Enablement+Tools/26582514.html</guid>
   <pubDate>Mon, 01 Jun 2026 14:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	  </item>
  <item>
   <title>SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools</title>
   <link>http://www.streetinsider.com/Business+Wire/SCIEX+Launches+the+novus+V55+System+With+SCIEX+OS+5.0+Software+and+AI+Enablement+Tools/26582514.html</link>
   <description>
&lt;p&gt;    MARLBOROUGH, Mass.--(BUSINESS WIRE)--
At ASMS, &lt;a target=&quot;_blank&quot; rel=&quot;nofollow&quot; href=&quot;https://cts.businesswire.com/ct/CT?id=smartlink&amp;amp;url=http%3A%2F%2Fwww.sciex.com&amp;amp;esheet=54545425&amp;amp;newsitemid=20260601916060&amp;amp;lan=en-US&amp;amp;anchor=SCIEX&amp;amp;index=1&amp;amp;md5=1a1a904d9ab3735f1cc2e39abab752ea&quot; shape=&quot;rect&quot;&gt;SCIEX&lt;/a&gt;, a Danaher company and leader in life science analytical technologies, launched the novus V55 system - a next-generation triple quadrupole mass spectrometer designed for the realities of high-pressure, results-driven labs. The system provides exceptional sensitivity and accelerated output, in a smaller footprint and with improved energy efficiency when compared to the SCIEX 5500+ system. This quantitative solution expands testing capabilities across pesticide and food analysis, pharmaceutical impurities, bioanalysis, PFAS testing and additional applications.

&lt;/p&gt;&lt;p id=&quot;news-body-cta&quot;&gt;This press release features multimedia. View the full release here: &lt;a target=&quot;_blank&quot; href=&quot;https://www.businesswire.com/news/home/20260601916060/en/&quot; rel=&quot;nofollow&quot;&gt;https://www.businesswire.com/news/home/20260601916060/en/&lt;/a&gt;&lt;/p&gt;&lt;div</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/SCIEX+Launches+the+novus+V55+System+With+SCIEX+OS+5.0+Software+and+AI+Enablement+Tools/26582514.html</guid>
   <pubDate>Mon, 01 Jun 2026 14:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00017863</category>
   	  </item>
  <item>
   <title>Citi Resumes Danaher (DHR) at Buy</title>
   <link>http://www.streetinsider.com/New+Coverage/Citi+Resumes+Danaher+%28DHR%29+at+Buy/26545587.html</link>
   <description>&lt;p&gt;Citi analyst Patrick Donnelly resumes coverage on Danaher (NYSE: DHR) with a Buy rating and a price target of $230.00.&lt;/p&gt;&lt;p&gt;For an analyst ratings summary and ratings history on Danaher &lt;a href=&quot;http://www.streetinsider.com/rating_history.php?q=DHR&quot;&gt;click here&lt;/a&gt;. For more ratings news on Danaher &lt;a href=&quot;http://www.streetinsider.com/stock_lookup_news.php?q=DHR&amp;amp;type=analyst&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;&lt;p&gt;Shares of Danaher closed at $172.00 yesterday.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/New+Coverage/Citi+Resumes+Danaher+%28DHR%29+at+Buy/26545587.html</guid>
   <pubDate>Tue, 26 May 2026 06:58:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	  </item>
  <item>
   <title>China holds roundtable with over 50 foreign pharmaceutical firms</title>
   <link>http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</link>
   <description>&lt;p&gt;Investing.com -- China's commerce ministry met with representatives from more than 50 foreign pharmaceutical companies on Friday, according to a ministry statement.&lt;/p&gt;&lt;p&gt;The meeting included companies such as Sanofi, Novartis, BD, Danaher, Merck, Eli Lilly, and Gilead Sciences, the statement showed.&lt;/p&gt;&lt;p&gt;Ling Ji, a vice commerce minister who led the meeting, said China is committed to improving pricing mechanisms and regulatory systems for the health care sector. Ji added that China welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</guid>
   <pubDate>Fri, 22 May 2026 09:54:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>China holds roundtable with over 50 foreign pharmaceutical firms</title>
   <link>http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</link>
   <description>&lt;p&gt;Investing.com -- China's commerce ministry met with representatives from more than 50 foreign pharmaceutical companies on Friday, according to a ministry statement.&lt;/p&gt;&lt;p&gt;The meeting included companies such as Sanofi, Novartis, BD, Danaher, Merck, Eli Lilly, and Gilead Sciences, the statement showed.&lt;/p&gt;&lt;p&gt;Ling Ji, a vice commerce minister who led the meeting, said China is committed to improving pricing mechanisms and regulatory systems for the health care sector. Ji added that China welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</guid>
   <pubDate>Fri, 22 May 2026 09:54:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>China holds roundtable with over 50 foreign pharmaceutical firms</title>
   <link>http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</link>
   <description>&lt;p&gt;Investing.com -- China's commerce ministry met with representatives from more than 50 foreign pharmaceutical companies on Friday, according to a ministry statement.&lt;/p&gt;&lt;p&gt;The meeting included companies such as Sanofi, Novartis, BD, Danaher, Merck, Eli Lilly, and Gilead Sciences, the statement showed.&lt;/p&gt;&lt;p&gt;Ling Ji, a vice commerce minister who led the meeting, said China is committed to improving pricing mechanisms and regulatory systems for the health care sector. Ji added that China welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</guid>
   <pubDate>Fri, 22 May 2026 09:54:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>China holds roundtable with over 50 foreign pharmaceutical firms</title>
   <link>http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</link>
   <description>&lt;p&gt;Investing.com -- China's commerce ministry met with representatives from more than 50 foreign pharmaceutical companies on Friday, according to a ministry statement.&lt;/p&gt;&lt;p&gt;The meeting included companies such as Sanofi, Novartis, BD, Danaher, Merck, Eli Lilly, and Gilead Sciences, the statement showed.&lt;/p&gt;&lt;p&gt;Ling Ji, a vice commerce minister who led the meeting, said China is committed to improving pricing mechanisms and regulatory systems for the health care sector. Ji added that China welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</guid>
   <pubDate>Fri, 22 May 2026 09:54:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>China holds roundtable with over 50 foreign pharmaceutical firms</title>
   <link>http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</link>
   <description>&lt;p&gt;Investing.com -- China's commerce ministry met with representatives from more than 50 foreign pharmaceutical companies on Friday, according to a ministry statement.&lt;/p&gt;&lt;p&gt;The meeting included companies such as Sanofi, Novartis, BD, Danaher, Merck, Eli Lilly, and Gilead Sciences, the statement showed.&lt;/p&gt;&lt;p&gt;Ling Ji, a vice commerce minister who led the meeting, said China is committed to improving pricing mechanisms and regulatory systems for the health care sector. Ji added that China welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</guid>
   <pubDate>Fri, 22 May 2026 09:54:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>China holds roundtable with over 50 foreign pharmaceutical firms</title>
   <link>http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</link>
   <description>&lt;p&gt;Investing.com -- China's commerce ministry met with representatives from more than 50 foreign pharmaceutical companies on Friday, according to a ministry statement.&lt;/p&gt;&lt;p&gt;The meeting included companies such as Sanofi, Novartis, BD, Danaher, Merck, Eli Lilly, and Gilead Sciences, the statement showed.&lt;/p&gt;&lt;p&gt;Ling Ji, a vice commerce minister who led the meeting, said China is committed to improving pricing mechanisms and regulatory systems for the health care sector. Ji added that China welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</guid>
   <pubDate>Fri, 22 May 2026 09:54:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>China holds roundtable with over 50 foreign pharmaceutical firms</title>
   <link>http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</link>
   <description>&lt;p&gt;Investing.com -- China's commerce ministry met with representatives from more than 50 foreign pharmaceutical companies on Friday, according to a ministry statement.&lt;/p&gt;&lt;p&gt;The meeting included companies such as Sanofi, Novartis, BD, Danaher, Merck, Eli Lilly, and Gilead Sciences, the statement showed.&lt;/p&gt;&lt;p&gt;Ling Ji, a vice commerce minister who led the meeting, said China is committed to improving pricing mechanisms and regulatory systems for the health care sector. Ji added that China welcomes pharmaceutical companies from all countries to deepen their presence in the Chinese market.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Investing/China+holds+roundtable+with+over+50+foreign+pharmaceutical+firms/26539410.html</guid>
   <pubDate>Fri, 22 May 2026 09:54:34 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">BDX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LLY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">SNY</category>
   	  </item>
  <item>
   <title>Henry Schein elects William Daniel as independent chairman</title>
   <link>http://www.streetinsider.com/Board+Changes/Henry+Schein+elects+William+Daniel+as+independent+chairman/26538682.html</link>
   <description>&lt;p&gt;Henry Schein Inc. (NASDAQ: HSIC) announced that its board of directors has elected William K. &quot;Dan&quot; Daniel as independent chairman of the board, effective May 21, 2026. Daniel succeeds Stanley M. Bergman, who retired from the board following 44 years as a director and was named chairman emeritus.&lt;/p&gt;&lt;p&gt;Daniel joined the Henry Schein board of directors in May 2025. He previously served for 14 years as executive vice president at Danaher Corporation (NYSE: DHR), where he oversaw multiple business segments including Danaher's dental portfolio. Daniel also served as a board director at Envista Holdings Corporation (NYSE: NVST) when it was spun</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Henry+Schein+elects+William+Daniel+as+independent+chairman/26538682.html</guid>
   <pubDate>Fri, 22 May 2026 08:00:59 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HSIC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVST</category>
   	  </item>
  <item>
   <title>Henry Schein elects William Daniel as independent chairman</title>
   <link>http://www.streetinsider.com/Board+Changes/Henry+Schein+elects+William+Daniel+as+independent+chairman/26538682.html</link>
   <description>&lt;p&gt;Henry Schein Inc. (NASDAQ: HSIC) announced that its board of directors has elected William K. &quot;Dan&quot; Daniel as independent chairman of the board, effective May 21, 2026. Daniel succeeds Stanley M. Bergman, who retired from the board following 44 years as a director and was named chairman emeritus.&lt;/p&gt;&lt;p&gt;Daniel joined the Henry Schein board of directors in May 2025. He previously served for 14 years as executive vice president at Danaher Corporation (NYSE: DHR), where he oversaw multiple business segments including Danaher's dental portfolio. Daniel also served as a board director at Envista Holdings Corporation (NYSE: NVST) when it was spun</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Henry+Schein+elects+William+Daniel+as+independent+chairman/26538682.html</guid>
   <pubDate>Fri, 22 May 2026 08:00:59 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HSIC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVST</category>
   	  </item>
  <item>
   <title>Henry Schein elects William Daniel as independent chairman</title>
   <link>http://www.streetinsider.com/Board+Changes/Henry+Schein+elects+William+Daniel+as+independent+chairman/26538682.html</link>
   <description>&lt;p&gt;Henry Schein Inc. (NASDAQ: HSIC) announced that its board of directors has elected William K. &quot;Dan&quot; Daniel as independent chairman of the board, effective May 21, 2026. Daniel succeeds Stanley M. Bergman, who retired from the board following 44 years as a director and was named chairman emeritus.&lt;/p&gt;&lt;p&gt;Daniel joined the Henry Schein board of directors in May 2025. He previously served for 14 years as executive vice president at Danaher Corporation (NYSE: DHR), where he oversaw multiple business segments including Danaher's dental portfolio. Daniel also served as a board director at Envista Holdings Corporation (NYSE: NVST) when it was spun</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Board+Changes/Henry+Schein+elects+William+Daniel+as+independent+chairman/26538682.html</guid>
   <pubDate>Fri, 22 May 2026 08:00:59 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DHR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">HSIC</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">NVST</category>
   	  </item>
 </channel>
</rss>
